DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Bone repair & regeneration Pipeline Highlights - 2017" drug pipelines to their offering.
This report, Bone repair & regeneration Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Bone repair & regeneration market. It covers emerging therapies for Bone repair & regeneration in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Bone repair & regeneration pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Bone repair & regeneration pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Bone repair & regeneration pipeline products by the company.
Short-term Launch Highlights:
Find out which Bone repair & regeneration pipeline products will be launched in the US and Ex-US till 2020.
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/l2nfrp/bone_repair_and